Richards Timothy T. 4

What Happened

• Timothy T. Richards, a director of ClearPoint Neuro, was granted 12,820 restricted stock units (RSUs) on May 21, 2026. The Form 4 reports the award as a derivative grant at $0.00 per unit (standard for RSU awards; no cash purchase).
• Each RSU represents a contingent right to receive one share of CLPT common stock upon vesting. The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the day immediately preceding the company's 2027 annual meeting of stockholders.

Key Details

• Transaction date: 2026-05-21; Filing date (Form 4): 2026-05-26 (appears to be filed one business day after the 2-business-day Form 4 deadline).
• Grant: 12,820 RSUs; Reported price: $0.00 (derivative award).
• Post-transaction shares owned: not specified in the provided filing.
• Footnotes: F1 — each RSU = right to one share on vesting; F2 — vesting on first anniversary or immediately before 2027 annual meeting.
• Transaction code: A (award/grant). No 10b5-1 plan, tax-withholding sale, or exercise reported.

Context

• RSU grants are compensation/retention awards, not open-market purchases or sales, and do not represent immediate share ownership until vesting and settlement.
• Such awards are common for directors as part of pay and governance practices; they should be interpreted as compensation-related rather than a direct bullish or bearish market signal.